D07.6

Clinical Causes: Genetic mutations affecting cell cycle regulation Human papillomavirus (HPV) infection, particularly high-risk strains Exposure to certain chemicals or toxins History of other related cancers or precancerous conditions Immunosuppression, for example, in organ transplant recipients Chronic irritation or inflammation of the genital area

Key Symptoms: Visible lesions or growths on the genital skin or tissues Persistent skin changes, such as thickening or discoloration Unexplained bleeding or discharge from the affected area Sensation of discomfort, itching, or pain in the genital region Typically, the condition may be asymptomatic and discovered during routine examination

Diagnosis Path: Doctors may recommend several diagnostic steps to confirm carcinoma in situ, including: - **Physical examination** to identify visible or palpable abnormalities - **Biopsy** of suspicious lesions for histopathological analysis - **Histology** to observe cellular atypia confined to the epithelium - **Imaging studies**, such as ultrasound or MRI, to assess the extent and involvement of neighboring tissues, especially if deeper structures are suspected

Treatment Protocols: Treatment options aim to eliminate the abnormal, non-invasive cells and prevent progression to invasive cancer. Approaches may include: - **Surgical excision** of the lesion or affected tissue - **Topical therapies**, such as immune response modifiers (e.g., imiquimod), to stimulate healing - **Laser therapy** to remove or ablate abnormal tissue - **Cryotherapy**, which involves freezing abnormal cells - **Regular follow-up** to monitor for recurrence or new lesions The choice of treatment depends on the lesion's location, size, patient health status, and preferences, emphasizing a personalized approach in management.